Gut microbiota plays a role in the pathophysiology of metabolic diseases, which include
nonalcoholic fatty liver diseases, through the gut–liver axis. To date, clinical guidelines …

AIM: To examine the impact of gut microbiota on non alcoholic fatty liver disease (NAFLD)
pathogenesis. DATA SYNTHESIS: Emerging evidence suggests a strong interaction …

The liver integrates metabolic outcomes with nutrient intake while preventing harmful signals
derived from the gut to spread throughout the body. Direct blood influx from the …

The gut microbiota is a complex and plastic consortium of microorganisms that are intricately
connected with human physiology. The liver is a central immunological organ that is …

The gut microbiome plays a key role in the health-disease balance in the human body.
Although its composition is unique for each person and tends to remain stable throughout …

The gut microbiome is the natural intestinal inhabitant that has been recognized recently as
a major player in the maintenance of human health and the pathophysiology of many …

Recent research has suggested a role for the intestinal microbiota in the pathogenesis and
potential treatment of a wide range of liver diseases. The intestinal microbiota and bacterial …

The gut microbiome, a diverse microbial community in the gastrointestinal tract, plays a
pivotal role in the maintenance of health. The gut microbiome metabolizes dietary and host …

Introduction: Nonalcoholic fatty liver disease (NAFLD) is one of the most common and
increasing liver diseases worldwide with a prevalence of 20–33%. NAFLD may progress to …

Gut microbiota changes are important in determining the occurrence and progression of
chronic liver disease related to alcohol, nonalcoholic fatty liver disease, and cirrhosis …